It has been possible to record in detail a renal transplant patient with HBs antigenaemia from before the onset until the cessation of carriage while he remained on immunosuppression and retained the transplanted kidney for 12 years.
Case report A man aged 35 received a cadaver kidney on 6 August 1968 which was rejected and removed on 9 September 1968. After bilateral nephrectomy on 14 October 1968 he was given a second cadaver kidney on 9 November 1968. He became a carrier by 5 December 1968 and his level of antigenaemia was subsequently found to be very high. His renal function recovered well and he was discharged on 24 December 1968, since when he has remained well with good renal output. His early history was recorded in 1970.1
Methods
The extent of HBs antigenaemia was initially measured by the complement fixation test (CFT) which was replaced by the introduction of the reverse passive haemagglutination test (RPHA) in 1974.2 The RPHA test (Hepatest, Wellcome Reagents Ltd) titres are about two-to fourfold higher than those of the CFT with this patient, which compares well with observations on other ad subtype carriers.3
The radioimmunoassay test (RIA) used was Ausria II (Abbot Laboratories Ltd).
Accepted for publication 10 September 1980 The proportion of 42 nm HBs antigen (Dane) particles was derived from counts made on electron micrographs of centrifuged antigen in serum samples, as previously described,' and from 1973 onwards antiserum had to be added to concentrate the antigen. 4 The anti-HBc test used was counter-immunoelectrophoresis.5 RIA tests for anti-HBc were undertaken by Dr DS Dane, Middlesex Hospital, who was also able to demonstrate anti-HBs in the 1979 sample by means of RIA.
Results and discussion
The patient already had anti-HBc by 5 July 1968, before his first transplant on 6 August 1968, so it is likely that his liver was already infected and that his antigenaemia was the result of immunosuppression after the second transplant on 9 November 1968, that is, he had reactivation or recrudescence of existing infection and not a primary infection.8
Antigenaemia was found within 26 days of the second transplant on 9 November 1968 and reached a very high blood level (approx. 1011 particles/ml), which was maintained for 4 years. During this time the patient was symptomless although his liver function tests were abnormally high (Table) .
Approximately 3% of the antigen particles were 42 nm (Dane) particles so that his serum was potentially highly infectious, and it is probably very fortunate that dialysis was not required during this time. We 
